Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib and gemcitabine in advanced pancreatic cancer
NCT01601808Phase 2Completed
- Sponsor
- University of Liverpool
- Start
- Oct 2011
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
A Phase 2 trial of vandetanib in pancreatic cancer (PC), sponsored by University of Liverpool. Started Oct 2011; status: completed.
02
Drugs
vandetanib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01601808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601808.